Table 1 Baseline characteristics of 31 patients with BTC
From: Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
Characteristic | N | (%) |
|---|---|---|
Sex | ||
Male | 13 | 42 |
Female | 18 | 58 |
Age, years | ||
Median | 63 | |
Range | 38–75 | |
Karnofsky score | ||
70 | 1 | 3 |
80 | 4 | 13 |
90 | 6 | 19 |
100 | 20 | 65 |
Primary cancer site | ||
Gallbladder | 10 | 32 |
Intrahepatic bile ducts | 14 | 45 |
Extrahepatic | 7 | 23 |
Disease at presentation | ||
Locally advanced | 3 | 10 |
Metastatic | 28 | 90 |
Metastatic sites | ||
Liver | 14 | 45 |
Lung | 6 | 19 |
Lymph nodes | 19 | 61 |
Prior therapy | ||
None | 17 | 55 |
Surgery | 7 | 23 |
Endoscopic biliary stenting | 6 | 19 |
Radiochemotherapy and stent | 1 | 3 |
Chemotherapy | 0 | 0 |
Presenting symptom | ||
Pain | 16 | 52 |
Jaundice | 5 | 16 |
Weight loss | 4 | 13 |
None | 2 | 6 |
Fever | 2 | 6 |
Fatigue | 2 | 6 |
Total | 20 | 65 |
Endoscopic biliary stenting during chemotherapy | 3 | 10 |
